Hudson Valley Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Hudson Valley Investment Advisors's GILD Position: Q4 2018 in Review
Hudson Valley Investment Advisors sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,280 shares — an estimated $253K sold.
Hudson Valley Investment Advisors first reported a position in GILD in Q2 2015 and held it in 14 quarters. The position peaked at $1.54M in Q2 2016. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.
- Hudson Valley Investment Advisors reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
- Hudson Valley Investment Advisors sold 3,280 Gilead Sciences shares in Q4 2018, an estimated $253K.
- Hudson Valley Investment Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 14 quarters.
- Hudson Valley Investment Advisors's Gilead Sciences position peaked at $1.54M in Q2 2016.
- 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.
Based on Hudson Valley Investment Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.